My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 2233

    1.

    Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.

    Gould MK, Kuschner WG, Rydzak CE, Maclean CC, Demas AN, Shigemitsu H, Chan JK, Owens DK.

    Ann Intern Med. 2003 Dec 2;139(11):879-92. Review.PMID: 14644890 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer.

    Alongi F, Ragusa P, Montemaggi P, Bona CM.

    Tumori. 2006 Jul-Aug;92(4):327-33.PMID: 17036525 [PubMed - indexed for MEDLINE]Related articles

    3.

    F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.

    Berlangieri SU, Scott AM, Knight SR, Fitt GJ, Hennessy OF, Tochon-Danguy HJ, Clarke CP, McKay WJ.

    Eur J Cardiothorac Surg. 1999 Sep;16 Suppl 1:S25-30.PMID: 10536941 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.

    Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, Ojha B.

    Ann Thorac Surg. 2005 Jan;79(1):263-8.PMID: 15620955 [PubMed - indexed for MEDLINE]Related articles

    5.

    Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.

    Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Bogaert J, Maes A, Deneffe GJ, Nackaerts KL, Verschakelen JA, Lerut TE, Mortelmans LA, Demedts MG.

    J Clin Oncol. 1998 Jun;16(6):2142-9.PMID: 9626214 [PubMed - indexed for MEDLINE]Related articles

    6.

    Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.

    Vansteenkiste JF, Stroobants SG, De Leyn PR, Dupont PJ, Verschakelen JA, Nackaerts KL, Mortelmans LA.

    Chest. 1997 Dec;112(6):1480-6.PMID: 9404742 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

    Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN.

    Thorax. 1997 May;52(5):438-41.PMID: 9176535 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer.

    Weng E, Tran L, Rege S, Safa A, Sadeghi A, Juillard G, Mark R, Santiago S, Brown C, Mandelkern M.

    Am J Clin Oncol. 2000 Feb;23(1):47-52.PMID: 10683077 [PubMed - indexed for MEDLINE]Related articles

    9.

    Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration.

    Aquino SL, Asmuth JC, Alpert NM, Halpern EF, Fischman AJ.

    J Comput Assist Tomogr. 2003 Jul-Aug;27(4):479-84.PMID: 12886128 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer.

    Gupta NC, Graeber GM, Rogers JS 2nd, Bishop HA.

    Ann Surg. 1999 Feb;229(2):286-91.PMID: 10024112 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.

    Poncelet AJ, Lonneux M, Coche E, Weynand B, Noirhomme P; Groupe d'Oncologie Thoracique des Cliniques Saint-Luc.

    Eur J Cardiothorac Surg. 2001 Sep;20(3):468-74; discussion 474-5.PMID: 11509265 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Preoperative staging of non-small-cell lung cancer with positron-emission tomography.

    Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koëter GH, Fidler V, Pruim J, Groen HJ.

    N Engl J Med. 2000 Jul 27;343(4):254-61.PMID: 10911007 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.

    Lee BE, Redwine J, Foster C, Abella E, Lown T, Lau D, Follette D.

    J Thorac Cardiovasc Surg. 2008 Mar;135(3):615-9. Epub 2008 Jan 11.PMID: 18329480 [PubMed - indexed for MEDLINE]Related articles

    14.

    Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

    Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC.

    N Engl J Med. 2003 Jun 19;348(25):2500-7.PMID: 12815135 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The size of mediastinal lymph nodes and its relation with metastatic involvement: a meta-analysis.

    de Langen AJ, Raijmakers P, Riphagen I, Paul MA, Hoekstra OS.

    Eur J Cardiothorac Surg. 2006 Jan;29(1):26-9. Epub 2005 Dec 6. Review.PMID: 16337397 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes.

    Al-Sarraf N, Gately K, Lucey J, Wilson L, McGovern E, Young V.

    Lung Cancer. 2008 Apr;60(1):62-8. Epub 2007 Oct 24.PMID: 17920724 [PubMed - indexed for MEDLINE]Related articles

    17.

    Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.

    Gupta NC, Graeber GM, Bishop HA.

    Chest. 2000 Mar;117(3):773-8.PMID: 10713005 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.

    Eubank WB, Mankoff DA, Takasugi J, Vesselle H, Eary JF, Shanley TJ, Gralow JR, Charlop A, Ellis GK, Lindsley KL, Austin-Seymour MM, Funkhouser CP, Livingston RB.

    J Clin Oncol. 2001 Aug 1;19(15):3516-23.PMID: 11481358 [PubMed - indexed for MEDLINE]Related articles

    19.

    The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.

    Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.

    Clin Nucl Med. 2007 Aug;32(8):607-12.PMID: 17667432 [PubMed - indexed for MEDLINE]Related articles

    20.

    How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer?

    Liewald F, Grosse S, Storck M, Guhlmann A, Halter G, Reske S, Sunder-Plassmann L.

    Thorac Cardiovasc Surg. 2000 Apr;48(2):93-6.PMID: 11028710 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity